Case Studies

Filter Articles

All Categories

All Categories Senior Appointments Team Builds

Medical Affairs team support Top-10 global Pharma in appointing Senior Medical Director

Compass Life Sciences’ Medical Affairs team recently supported a Top-10 global Pharmaceutical business who have operations in more than 80 countries world-wide, to appoint a Senior Medical Director as part of a key hire for the organisation.

CLS place Senior Medical Director at multinational pharmaceutical company

Compass Life Sciences was mandated to support a multinational pharmaceutical company in sourcing a Senior Medical Director to assist the Country Medical Director with both existing and upcoming products.

Compass Life Sciences place Vice President – Women’s Health and Endocrinology – for family-owned pharma

Compass Life Sciences supported a family-owned global pharmaceutical business in the appointment of a Vice President to focus on Women’s Health and Endocrinology. Read all about the process, reason and purpose, and outcome.

CLS support US-based Pharma new team build in Europe to support product launch

Compass Life Sciences has recently partnered with a US-based Pharmaceutical company preparing to launch a new Cardiovascular Disease Risk Lowering and Lipid Lowering Tri-glyceride drug across Europe.

CLS appoint a Clinical Research Site Director for a rapidly growing CRO

The CLS Clinical Research team recently supported a rapidly growing CRO in the appointment of a Clinical Research Site Director, as part of a business-critical hire, to ensure their growth plans continued on the planned trajectory.

Compass Life Sciences support a leading US Biopharma expand into Europe

Compass Life Sciences have partnered with a leading US based Pharmaceutical business considered to be a market-leader in cardiovascular disease management, to support ambitious growth plans into the European markets.

EXPLORE THE COMPASS GROUP

Compass Associates

Compass Executives

Compass Corporate Services

Compass Recruitment Solutions (CRS) launched in major rebrand